1. Home
  2. CTNM vs BEEP Comparison

CTNM vs BEEP Comparison

Compare CTNM & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • BEEP
  • Stock Information
  • Founded
  • CTNM 2009
  • BEEP 2015
  • Country
  • CTNM United States
  • BEEP United States
  • Employees
  • CTNM N/A
  • BEEP N/A
  • Industry
  • CTNM
  • BEEP Blank Checks
  • Sector
  • CTNM
  • BEEP Finance
  • Exchange
  • CTNM Nasdaq
  • BEEP Nasdaq
  • Market Cap
  • CTNM 142.3M
  • BEEP 162.0M
  • IPO Year
  • CTNM 2024
  • BEEP N/A
  • Fundamental
  • Price
  • CTNM $5.77
  • BEEP $3.85
  • Analyst Decision
  • CTNM Strong Buy
  • BEEP Strong Buy
  • Analyst Count
  • CTNM 4
  • BEEP 2
  • Target Price
  • CTNM $22.50
  • BEEP $6.75
  • AVG Volume (30 Days)
  • CTNM 366.4K
  • BEEP 118.6K
  • Earning Date
  • CTNM 08-12-2025
  • BEEP 08-12-2025
  • Dividend Yield
  • CTNM N/A
  • BEEP N/A
  • EPS Growth
  • CTNM N/A
  • BEEP N/A
  • EPS
  • CTNM N/A
  • BEEP N/A
  • Revenue
  • CTNM N/A
  • BEEP $36,416,000.00
  • Revenue This Year
  • CTNM N/A
  • BEEP $5.22
  • Revenue Next Year
  • CTNM N/A
  • BEEP $5.13
  • P/E Ratio
  • CTNM N/A
  • BEEP N/A
  • Revenue Growth
  • CTNM N/A
  • BEEP 13.81
  • 52 Week Low
  • CTNM $3.35
  • BEEP $2.48
  • 52 Week High
  • CTNM $21.58
  • BEEP $4.86
  • Technical
  • Relative Strength Index (RSI)
  • CTNM N/A
  • BEEP 43.82
  • Support Level
  • CTNM N/A
  • BEEP $3.66
  • Resistance Level
  • CTNM N/A
  • BEEP $3.93
  • Average True Range (ATR)
  • CTNM 0.00
  • BEEP 0.21
  • MACD
  • CTNM 0.00
  • BEEP -0.05
  • Stochastic Oscillator
  • CTNM 0.00
  • BEEP 19.19

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.

Share on Social Networks: